非小细胞肺癌个体化疗：由实验研究向临床过渡
摘要
标准化疗（standard chemotherapy）是目前非小细胞肺癌（NSCLC）最常接受的药物治疗方式，标准化疗方案有紫杉醇联合铂类、吉西他滨联合顺铂、异长春花碱联合顺铂。上述方案经大样本多中心前瞻性Ⅲ期临床试验，客观有效率只有21％。提高肺癌化疗的效果是临床迫切需要解决的难题。最近3～5年，抗肿瘤药物遗传学／基因组学的快速发展已经能够确定一些化疗药物疗效相关的关键基因。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2008年第5期344-345,共2页
Chinese Journal of Pathology
参考文献13
-
1Lord RV ,Brabender J, Gandara D, et al. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-smaU cell lung cancer. Clin Cancer Res, 2002,8(7) :2286-2291.
-
2Olaussen KA,Dunant A,Fouret P,et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med, 2006,355(10) :983-991.
-
3Cobo M, Isla D, Massuti B, et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase Ⅲ trial in non-small-cell lung cancer. J Clin Oncol,2007,25 ( 19 ) : 2747-2754.
-
4Zhou W, Gurubhagavatula S, Liu G, et al. Excision repair crosscomplementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinumbased chemotherapy. Clin Cancer Res ,2004, 10( 15 ) :4939-4943.
-
5Zheng Z, Chen T, Li X, et al. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med, 2007,356(8) : 800-808.
-
6Rosell R, Felip E, Taron M, et al. Gene expression as a predictive marker of outcome in stage Ⅱ B-ⅢA-ⅢB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery. Clin Cancer Res,2004,10( 12 pt 2) :4215s-4219s.
-
7Bepler G, Zheng Z, Gautam A, et al. Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance. Lung Cancer, 2005,47 ( 2 ) : 183-192.
-
8Rosell R, Skrzypski M, Jassem E, et al. BRCA1: a novel prognostic factor in resected non-small-cell lung cancer. PLoS ONE, 2007,2( 11 ) :e1129.
-
9Taron M, Rosell R, Felip E, et al. BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. Hum Mol Genet,2004,13 ( 20 ) : 2443 -2449.
-
10Seve P, Mackey J, Isaac S, et al. Class Ⅲ beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel. Mol Cancer Ther,2005 ,4(12) :2001-2007.
-
1钱晓萍,刘宝瑞.非小细胞肺癌个体化疗-提高化疗疗效现实之路[J].现代肿瘤医学,2008,16(10):1823-1826. 被引量：1
-
2周鑫,揭志刚.胃癌个体化化疗[J].江西医学院学报,2009,49(4):132-134. 被引量：4
-
3邹征云,沈洁,刘宝瑞.伊立替康疗效相关生物标志的研究进展[J].癌症进展,2012,10(5):498-501. 被引量：2
-
4钱晓萍,刘宝瑞.非小细胞肺癌个体化疗—提高化疗疗效现实之路[J].实用临床医药杂志,2008,12(5):19-22.
-
5朱立峰,项鹤彬,赵志军,李胜华,叶陈波,任建林.早期乳腺癌保乳手术与改良根治术疗效分析[J].中国基层医药,2011,18(22):3096-3098. 被引量：7
-
6宁连胜,刘磊,郎义方,马淑资,李云英,石松魁,于冬,方志沂,惠锐,侯子正,毛慧生,孙慧,赵文华,王垣,李丽庆,张万岭,赵宝林,王文治,韩来声,刘长君,张天泽.晚期乳腺癌的个体化疗[J].中国肿瘤临床,1990,17(5):287-289.
-
7刘宝瑞,钱晓萍.大肠癌和胃癌个体化疗的现状与未来[J].世界华人消化杂志,2007,15(18):1979-1982. 被引量：4
-
8邹青峰,楮忠华,马磊,李志彪,李卫东,陈文晟,金川,吴迪.肺癌体外药敏试验与临床疗效之间的关系[J].广州医药,2006,37(1):24-27. 被引量：3
-
9麦麦提玉苏甫.亚合甫,阿不来提.司买提.左氧氟沙星联合标准化疗方案治疗肺结核的临床研究[J].中国医学创新,2011,8(27):59-60. 被引量：10
-
10陶德友,毕铁男,周申康,潘一红.腹腔镜直肠癌根治术30例分析[J].中国医师进修杂志,2011,34(17):66-67. 被引量：4
